ning of the 2018 Farm Bill, essentially reminding CBD manufacturers of FDA’s continued regulatory authority over CBD products. On the positive side, Gottlieb indicated that the FDA is open to engaging with industry players early to clarify uncertainty and to help develop a clear and consistent pathway for

d 986 (2d Cir. 1973) (excluding party from attending deposition of opposing party where he had a pattern of unlawful harassment of opposing party); Gottlieb v. County of Orange, 151 F.R.D. 258 (S.D.N.Y. 1993) (limiting persons who can attend depositions of nursing personnel in child abuse case); In re Sh

& BENEFITS US, Ex-IBM Worker Ask DC Circ. To Revive Tipster Suit tiLaw360 Rising Stars LAW FIRMS Bangs McCullen Beck Redden Blank Rome Cleary Gottlieb Cooley Costello Porter Cozen O'Connor Cranfill Sumner Cravath Swaine DLA Piper Davis Polk Edinger Leonard Elliott & Smith Epstein Becker Gr

FIRMS Advisors LLC Akin Gump Arent Fox Armstrong Teasdale Arnold & Porter Baker Marquart Ballard Spahr Christian & Barton Clark Hill Cleary Gottlieb Consovoy McCarthy Constantine Cannon Cravath Swaine Crowell & Moring DLA Piper Davis Polk Davis Wright Tremaine Debevoise & Plimpton Dechert